Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 26, 2015 11:36 ET | Source: Gradalis, Inc.

Gradalis, Inc. Announces Initiation of a Phase 3 Registration Study for Vigil(TM) in Ovarian Cancer

DALLAS, Feb. 26, 2015 (GLOBE NEWSWIRE) -- Gradalis Inc., a late-stage biopharmaceutical company, today announced that it has initiated a Phase 3 registration trial for its proprietary autologous...
June 18, 2014 09:30 ET | Source: Gradalis, Inc.

Gradalis, Inc. Announces Presentation of New Data

DALLAS, June 18, 2014 (GLOBE NEWSWIRE) -- Gradalis Inc., a late-stage oncology therapeutic company, today announced that new data from its lead cancer programs focused on its personalized...
June 04, 2014 09:15 ET | Source: Gradalis, Inc.

Gradalis, Inc. Announces Dr. Scott Gottlieb Joins Board of Directors

DALLAS, June 4, 2014 (GLOBE NEWSWIRE) -- Gradalis Inc., a late stage clinical company, today announced that Scott Gottlieb, MD has joined its board of directors. Dr Gottlieb, MD is a practicing...